ANIX News and Press, Anixa Biosciences Inc. From 01/25/19

SAN JOSE, Calif. , Jan. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it has made a recording of its January 24, 2019 conference call available on its website. ...

Anixa Biosciences, Inc. (ANIX) Outlook for 2019 January 24, 2019, 04:30 PM ET Company Participants Amit Kumar - Chairman, President and CEO Mike Catelani - COO and CFO Lewis Titterton - Lead Independent Director Conference Call Participants Jason Kolbert - Dawson James An...

SAN JOSE, Calif. , Jan. 24, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for the first patent ...